Bethesda, MD-Mutations in the gene encoding 2-5-oligoadenylate(2-5A)-dependentRNase L (RNASEL) have been found to be associated with prostate cancer inmembers of high-risk families. The recently published research comes frominvestigators from the National Institutes of Health's National Human GenomeResearch Institute and collaborators from industry and several other publicand private institutions.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.